Guidelines for Optimal Patient Outcomes Using Calcium Hydroxylapatite for Jawline Contour

BACKGROUND: Calcium hydroxylapatite (CaHA(+); Radiesse(+) [Merz North America, Inc., Raleigh, NC]) is the first FDA-approved injectable filler for subdermal and/or supraperiosteal injection to improve moderate-to-severe loss of jawline contour. CaHA has been recognized in the past for its ability to...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi, Amir, Green, Jeremy B, Kwok, Gideon P, Nichols, Kim, Rivkin, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120162/
https://www.ncbi.nlm.nih.gov/pubmed/37089169
http://dx.doi.org/10.1093/asjof/ojad019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120162/
https://www.ncbi.nlm.nih.gov/pubmed/37089169
http://dx.doi.org/10.1093/asjof/ojad019

Ejemplares similares